Straumann Holding AG Cash on Hand 2012-2021 | SAUHY

Straumann Holding AG cash on hand from 2012 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Straumann Holding AG cash on hand for the quarter ending December 31, 2021 was $0.966B, a 237.68% increase year-over-year.
  • Straumann Holding AG cash on hand for 2021 was $0.966B, a 43.17% increase from 2020.
  • Straumann Holding AG cash on hand for 2020 was $0.675B, a 156.02% increase from 2019.
  • Straumann Holding AG cash on hand for 2019 was $0.264B, a 7.87% decline from 2018.
Straumann Holding AG Annual Cash on Hand
(Millions of US $)
2021 $966
2020 $675
2019 $264
2018 $286
2017 $289
2016 $168
2015 $332
2014 $506
2013 $416
2012 $150
2011 $428
Straumann Holding AG Quarterly Cash on Hand
(Millions of US $)
2021-12-31 $966
2020-12-31 $675
2020-06-30 $395
2019-12-31 $264
2018-12-31 $286
2017-12-31 $289
2017-06-30 $143
2016-12-31 $168
2016-06-30 $315
2015-12-31 $332
2014-12-31 $506
2013-12-31 $416
2013-06-30 $344
2012-12-31 $150
2012-06-30 $126
2011-12-31 $428
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47